In the present study, we explored the expression profile and mode of action of CELF2 in our collection of GBM tissue samples representative of mitotic tumor territories enriched in OLIG2-positive cells or, conversely, non-mitotic tumor areas poor in OLIG2-positive cells [8,13]. Here, CELF2 is linked to neoplasm.